Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov;9(6):1145-1162.
doi: 10.1016/j.apsb.2019.08.003. Epub 2019 Aug 19.

Recent progress in drug delivery

Affiliations
Review

Recent progress in drug delivery

Chong Li et al. Acta Pharm Sin B. 2019 Nov.

Abstract

Drug delivery systems (DDS) are defined as methods by which drugs are delivered to desired tissues, organs, cells and subcellular organs for drug release and absorption through a variety of drug carriers. Its usual purpose to improve the pharmacological activities of therapeutic drugs and to overcome problems such as limited solubility, drug aggregation, low bioavailability, poor biodistribution, lack of selectivity, or to reduce the side effects of therapeutic drugs. During 2015-2018, significant progress in the research on drug delivery systems has been achieved along with advances in related fields, such as pharmaceutical sciences, material sciences and biomedical sciences. This review provides a concise overview of current progress in this research area through its focus on the delivery strategies, construction techniques and specific examples. It is a valuable reference for pharmaceutical scientists who want to learn more about the design of drug delivery systems.

Keywords: Application; Basic research; Delivery strategy; Drug delivery system; Pharmaceutics.

PubMed Disclaimer

Figures

Image 1
Graphical abstract
Figure 1
Figure 1
The schematic diagram of pH-triggered morphological transformation from self-assembled nanoparticles (NPs) to nanofibers (NFs) and a pre-nested host in a tumor where thermally sensitive drugs are located (Adapted from Ref.  with permission. Copyright © 2017 Wiley).
Figure 2
Figure 2
(A) The nanoparticle-based combination therapy. (B) Plasma drug concentrations after i.v. injection of the VYXEOS® liposomes and the free combo drugs in mice (Adapted from Ref.  with permission. Copyright © 2016, Elsevier and Ref.  with permission. Copyright © 2019, American Association for Cancer).
Figure 3
Figure 3
Schematic diagram of pH-tunable sticky vesicles, conventional uniformly functionalized nanoparticle with or without tether (PEG), and their affinity towards target cells with different receptor expressions.
Figure 4
Figure 4
Formation and advantages of prodrug nanomedicines (PNs).
Figure 5
Figure 5
a) The dynamic interaction between DOX and benzaldehyde via pH-sensitive benzoic–imine bond. b) Schematic illustration of the drug DOX self-gated MSNs with pH-responsive drug release property. c) Dynamically PEGylated and DOX self-gated MSNs with site-specific drug release at weak acidic tumor tissue/cells.

References

    1. Park K. Controlled drug delivery systems: past forward and future back. J Control Release. 2014;190:3–8. - PMC - PubMed
    1. Barenholz Y. Doxil® — the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160:117–134. - PubMed
    1. Kennon S., Tasch E.G., Arm R.N., Wig P.P. The relationship between plaque scores and the development of caries in adult dentition. Clin Prev Dent. 1979;1:26–31. - PubMed
    1. Li M., Shi K.R., Tang X., Wei J.J., Cun X.L., Chen X.X. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma. Eur J Pharm Sci. 2018;124:240–248. - PubMed
    1. Zhang T.H., Chen X., Xiao C.S., Zhuang X.L., Chen X.S. Synthesis of a phenylboronic ester-linked PEG-lipid conjugate for ROS-responsive drug delivery. Polym Chem. 2017;8:6209–6216.

LinkOut - more resources